Memorial Sloan-Kettering Cancer Center Commack: Clinical Trials at Commack

Browse our continually updated listing of clinical trials available to patients at Memorial Sloan-Kettering Cancer Center Commack below. You can also explore our complete listing of clinical trials available at Memorial Sloan-Kettering.

Showing 61 - 80 of 91 trials
Titlesort icon Investigator Disease(s)
A Phase II Study of Gemcitabine and Pazopanib in Previously Untreated Patients with Advanced Urothelial Cancers Who Cannot Receive Cisplatin
[Protocol 11-191] 		Bajorin, Dean
  • Bladder Cancer
  • Kidney Cancer
A Phase II Study of Gemcitabine and Cisplatin before Surgery in Patients with High-Grade Upper Tract Urothelial Carcinoma
[Protocol 10-208] 		Coleman, Jonathan
  • Kidney Cancer
A Phase II Study of Fulvestrant Alone or with GDC-0941 or GDC-0980 in Women with Advanced Breast Cancer Resistant to Aromatase Inhibitor Therapy
[Protocol 12-029] 		Dickler, Maura
  • Breast Cancer
A Phase II Study of Everolimus as Second-Line Therapy in the Treatment of Metastatic Renal Cell Carcinoma
[Protocol 11-197] 		Motzer, Robert
  • Kidney Cancer
A Phase II Study of Dose-Dense Temozolomide and Lapatinib for Recurrent Low- Grade and Anaplastic Ependymoma
[Protocol 09-031] 		Omuro, Antonio
  • Brain Tumors, Primary
    • Other Trials
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase II Study of Dose-Dense Doxorubicin and Cyclophosphamide followed by Eribulin Mesylate for the Adjuvant Treatment of Early-Stage Breast Cancer
[Protocol 10-190] 		Traina, Tiffany
  • Breast Cancer
A Phase II Study of Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
[Protocol 11-005] 		Lee, Nancy
  • Head & Neck Cancer
A Phase II Study of Combination Chemotherapy with and without Low-Dose Whole-Brain Radiation for Primary Central Nervous System Lymphoma
[Protocol 11-125] 		Omuro, Antonio
  • Lymphoma
    • Non-Hodgkin's Lymphoma
  • Pediatric Brain Tumors
    • CNS Cancer
A Phase II Study of Carboplatin and Bevacizumab for the Treatment of Recurrent Low-Grade and Anaplastic Ependymoma in Adults
[Protocol 11-146] 		Omuro, Antonio
  • Brain Tumors, Primary
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase II Study of Cabozantinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 12-097] 		Rizvi, Naiyer
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase II Study of Bortezomib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 12-222] 		Riely, Gregory
  • Lung Cancer, Non-Small Cell
A Phase II Study of Adjuvant Bevacizumab, Metronomic Chemotherapy, Diet, and Exercise After Preoperative Chemotherapy for Breast Cancer
[Protocol 11-063] 		Dickler, Maura
  • Breast Cancer
A Phase II Study Evaluating the Addition of Trastuzumab to Standard Therapy for HER2-Positive Esophageal Cancers
[Protocol 12-094] 		Wu, Abraham
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase II Study Evaluating Manuka Honey to Reduce Chemoradiation-Associated Esophagitis Pain during Lung Cancer Treatment
[Protocol 12-111] 		Rimner, Andreas
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
  • Lung Cancer, Small Cell
    • Other
A Phase I/II Trial of AUY-922 in Patients with Lung Adenocarcinoma with Acquired Resistance to Erlotinib or Gefitinib
[Protocol 11-015] 		Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I/II Study of Temsirolimus, Paclitaxel, and Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer
[Protocol 09-131] 		Fury, Matthew
  • Head & Neck Cancer
A Phase I/II Study of Sequential Chemoradiation Followed by Autologous Stem Cell Transplant in Patients with Untreated Advanced Mantle Cell Lymphoma
[Protocol 11-095] 		Zelenetz, Andrew
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I/II Study of Intrathecal Trastuzumab in Women with HER2-Positive Breast Cancer that Spread to the Spinal Fluid
[Protocol 12-123] 		Pentsova, Elena
  • Breast Cancer
A Phase I/II Study of Crizotinib and STA-9090 in ALK-Positive Lung Cancers
[Protocol 12-015] 		Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I/II Study of Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Patients with Relapsed/Refractory Indolent B-cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL)
[Protocol 05-103] 		Gerecitano, John
  • Leukemia
    • Chronic Lymphocytic Leukemia
  • Lymphoma